Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Real-World Evidence: Amylyx’s Use Of External Controls To Frame Relyvrio’s Survival Benefit Rife With Problems
Nov 10 2022
•
By
Sue Sutter
Amylyx attempted to rely on historical controls in showing a survival benefit with Relyvrio in a Phase II trial. • Source: Shutterstock
More from Drug Review Profiles
More from Product Reviews